Search Results - "KREMENCHUTZKY, M"

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease by Kremenchutzky, M., Rice, G. P. A., Baskerville, J., Wingerchuk, D. M., Ebers, G. C.

“…The clinical features of relapses and progression largely define multiple sclerosis phenotypes. A relapsing course is followed by chronic progression in some…”
Get full text

Survival in MS: A randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial by GOODIN, D. S, REDER, A. T, KNAPPERTZ, V, EBERS, G. C, CUTTER, G, KREMENCHUTZKY, M, OGER, J, LANGDON, D, RAMETTA, M, BECKMANN, K, DESIMONE, T. M

“…To examine the effects of interferon beta (IFNβ)-1b on all-cause mortality over 21 years in the cohort of 372 patients who participated in the pivotal…”
Get full text

Morphology-Specific Discrimination between MS White Matter Lesions and Benign White Matter Hyperintensities Using Ultra-High-Field MRI by Hosseini, Z, Matusinec, J, Rudko, D A, Liu, J, Kwan, B Y M, Salehi, F, Sharma, M, Kremenchutzky, M, Menon, R S, Drangova, M

“…Recently published North American Imaging in Multiple Sclerosis guidelines call for derivation of a specific radiologic definition of MS WM lesions and mimics…”
Get full text

Multiple sclerosis and faecal microbiome transplantation: are you going to eat that? by Wing, A C, Kremenchutzky, M

“…Gut microbiome interaction goes beyond commensal function as vitamin production or support nutrients digestion. It also interplays with the host immune system…”
Get more information

The ‘across the pons’ sign: A possible novel radiographic finding in natalizumab-associated progressive multifocal leukoencephalopathy by Budhram, A, Pelikan, JB, Kremenchutzky, M, Sharma, M

“…Highlights • Natalizumab is a treatment for relapsing-remitting MS that is associated with PML . • We report a possible novel ‘across the pons’ sign on MRI in…”
Get full text

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis by Wingerchuk, D M, Lesaux, J, Rice, G P A, Kremenchutzky, M, Ebers, G C

“…Background: Epidemiological and ecological studies suggest links between vitamin D deficiency and increased multiple sclerosis (MS) prevalence. Objective: To…”
Get full text

Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria by O’Connor, P, Kinkel, RP, Kremenchutzky, M

“…Approximately 85% of multiple sclerosis (MS) cases begin as clinically isolated syndromes (CIS). Results from the Controlled High-Risk Subjects Avonex®…”
Get full text

Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis by O'Connor, K.C, Lopez-Amaya, C, Gagne, D, Lovato, L, Moore-Odom, N.H, Kennedy, J, Krupp, L, Tenembaum, S, Ness, J, Belman, A, Boyko, A, Bykova, O, Mah, J.K, Stoian, C.A, Waubant, E, Kremenchutzky, M, Ruggieri, M, Bardini, M.R, Rensel, M, Hahn, J, Weinstock-Guttman, B, Yeh, E.A, Farrell, K, Freedman, M.S, Iivanainen, M, Bhan, V, Dilenge, M, Hancock, M.A, Gano, D, Fattahie, R, Kopel, L, Fournier, A.E, Moscarello, M, Banwell, B, Bar-Or, A

“…Abstract Anti-myelin basic protein (MBP) antibodies in pediatric-onset MS and controls were characterized. Serum samples were obtained from 94 children with MS…”
Get full text

The natural history of multiple sclerosis : a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis : a re-evaluation by KREMENCHUTZKY, M, COTTRELL, D, RICE, G, HADER, W, BASKERVILLE, J, KOOPMAN, W, EBERS, G. C

“…Classifications of multiple sclerosis subtypes have been largely based on clinical phenomenology. Nevertheless, definitions of relapse, remission and…”
Get full text

Prevalence of multiple sclerosis in Buenos Aires, Argentina using the capture-recapture method by Cristiano, E., Patrucco, L., Rojas, J. I., Cáceres, F., Carrá, A., Correale, J., Garcea, O., Gold, L., Tessler, J., Kremenchutzky, M.

“…Background:  Scarce data exist about multiple sclerosis (MS) prevalence in South America. The objective of the study is to determine the prevalence of MS in a…”
Get full text

The natural history of multiple sclerosis : a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis by COTTRELL, D. A, KREMENCHUTZKY, M, RICE, G. P. A, KOOPMAN, W. J, HADER, W, BASKERVILLE, J, EBERS, G. C

“…We report a natural history study of 216 patients with primary progressive (PP)- multiple sclerosis defined by at least 1 year of exacerbation-free progression…”
Get full text

Argentine Patagonia: prevalence and clinical features of multiple sclerosis by Melcon, MO, Gold, L, Carrá, A, Cáceres, F, Correale, J, Cristiano, E, Fernández Liguori, N, Garcea, O, Luetic, G, Kremenchutzky, M

“…There are few studies reporting multiple sclerosis prevalence rates in the Buenos Aires region, Argentina (latitude 34°S) (between 12–18.5/100 000…”
Get full text

Anticipation of age at onset in familial multiple sclerosis by Romero-Pinel, L., Martínez-Yélamos, S., Gubieras, L., Matas, E., Bau, L., Kremenchutzky, M., Arbizu, T.

“…Background and objective:  Anticipation of age at onset in the younger generations is a widely known characteristic of many diseases with genetic inheritance…”
Get full text

Corpus callosum atrophy in a patient with neuromyelitis optica by Alikhani, K, Lee, D H, Kremenchutzky, M

Get more information

High dose oral steroids commonly used to treat relapses in Canadian MS clinics by Morrow, S A, Metz, L M, Kremenchutzky, M

“…Glucocorticoid treatment improves the speed of functional recovery of acute multiple sclerosis (MS) relapses but has not been shown to provide any long-term…”
Get more information

The natural history of multiple sclerosis : a geographically based study 8: Familial multiple sclerosis by EBERS, G. C, KOOPMAN, W. J, HADER, W, SADOVNICK, A. D, KREMENCHUTZKY, M, MANDALFINO, P, WINGERCHUK, D. M, BASKERVILLE, J, RICE, G. P. A

“…We have examined the demographics and long-term outcome of 1044 patients with sporadic and familial multiple sclerosis in a population-based cohort from…”
Get full text

The natural history of multiple sclerosis : a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis by COTTRELL, D. A, KREMENCHUTZKY, M, RICE, G. P. A, HADER, W, BASKERVILLE, J, EBERS, G. C

“…The natural history of primary progressive multiple sclerosis (PP-multiple sclerosis) recently has been defined in a geographically based multiple sclerosis…”
Get full text

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis by Metz, Luanne M, Li, David K.B, Traboulsee, Anthony L, Duquette, Pierre, Eliasziw, Misha, Cerchiaro, Graziela, Greenfield, Jamie, Riddehough, Andrew, Yeung, Michael, Kremenchutzky, Marcelo, Vorobeychik, Galina, Freedman, Mark S, Bhan, Virender, Blevins, Gregg, Marriott, James J, Grand’Maison, Francois, Lee, Liesly, Thibault, Manon, Hill, Michael D, Yong, V. Wee

“…The risk of conversion from a first demyelinating event to MS was lower with minocycline than with placebo over 6 months but not over 24 months. Changes of…”
Get full text

Diagnostic brain MRI findings in primary progressive multiple sclerosis by Kremenchutzky, M, Lee, D, Rice, G P A, Ebers, G C

“…The clinical course of multiple sclerosis can be classified as relapsing from onset (relapsing-remitting), or progressive from onset (primary progressive…”
Get full text

Diagnostic brain MRI findings in primary progressive multiple sclerosis by Kremenchutzky, M., Lee, D., Rice, G.P.A., Ebers, G.C.

“…The clinical course of multiple sclerosis can be classified as relapsing from onset (relapsing-remitting), or progressive from onset (primary progressive -…”
Get full text